AVANZANITE BIOSCIENCE PARTNERS WITH ADVICENNE TO COMMERCIALIZE SIBNAYAL® FOR THE TREATMENT OF RARE KIDNEY DISEASE IN GERMANY, AUSTRIA, SWITZERLAND AND GREECE
• Advicenne agreement further validates Avanzanite’s unique businessmodel and establishes it as the go-to commercialization partner formedicines treating rare diseases across Europe. • Avanzanite now